Pharma and healthcare: sector news on Sunday 1 November 2026
Average tone +0.9 (neutral) across 3 companies with relevant coverage, from 11 stories.
How to read a score. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Company by company
| Company | Tone | Stories | What the coverage was about |
|---|---|---|---|
| AstraZeneca | +6.3 | 8 | Coverage centred on third-quarter results showing profit growth and an unchanged outlook, alongside a new cost-saving programme to fund the drug pipeline. |
| Haleon | −3.5 | 2 | Coverage centred on a reduction in Haleon's growth guidance and what it means for the investment case, which tilts the tone negative. |
| Smith & Nephew | 0.0 | 1 | |
| Convatec | — | 0 | |
| GSK | — | 0 |
Strongest stories in the sector
- +8.5 New targeted oncology medicine reaching the American market.
- +7.3 Third-quarter growth leaves full-year guidance unchanged, reassuring for investors.
- +7.0 Quarterly results showing profit expansion, though valuation concerns temper enthusiasm.
- +6.3 Shares helped lift the FTSE 100 on the day.
- −6.3 Lowered outlook for expansion prompts investors to reassess the company's story, mildly negative.}
- +5.5 Efficiency drive to free money for research and development.
- +5.2 Forward-looking coverage of growth prospects and pipeline plans for coming years.
- +4.5 Cost-cutting programme linked to its long-term revenue ambition.
- +2.0 Transcript of management's quarterly call; factual record with little new information.
- +0.5 Generic session commentary about the shares with no clear positive or negative news.
- 0.0 Market-commentary piece on the company with no clear positive or negative news.}],
Pharma and healthcare: every day · FTSE 100 overview for the day
Follow by email
A short, free morning email on how the news treated the Pharma and healthcare sector: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.